A Survey of Occurrence and Risk Assessment of Pharmaceutical Substances in the Great Lakes Basin

Ozone: Science and Engineering

Volumn 35, Issue 4, 2013, Pages 249-262

  Uslu, Merih Otker ^a,b   Jasim, Saad ^b   Arvai, Antonette ^b   Bewtra, Jatinder ^a   Biswas, Nihar ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b International Joint Commission   (Canada)

Author keywords

Contamination; Drinking Water; Great Lakes; Natural Water; Ozone; Pharmaceutical; Wastewater

Indexed keywords

CONCENTRATION RANGES; CONVENTIONAL TREATMENTS; DRINKING WATER SOURCES; GREAT LAKES; MACROLIDE ANTIBIOTICS; NATURAL WATERS; PHARMACEUTICAL COMPOUNDS; WASTEWATER TREATMENT PLANTS;

AMIDES; CAFFEINE; CONTAMINATION; DRUG PRODUCTS; EFFLUENTS; HEALTH RISKS; LAKES; OZONE; POTABLE WATER; RISK ASSESSMENT; RIVER POLLUTION; WASTEWATER;

ANTIBIOTICS;

EID: 84880403286     PISSN: 01919512     EISSN: 15476545     Source Type: Journal    
DOI: 10.1080/01919512.2013.793595     Document Type: Article

References (61)

1. Andreozzi, R., Canterino, M., Giudice, R.L., Marotta, R., Pinto, G. and Pollio, A. 2006. Lincomycin Solar Photodegradation, Algal Toxicity and Removal from Wastewaters by Means of Ozonation. Water Res., 40: 630 - 638.
2. Andresen, J. A., Muir, D., Ueno, D., Darling, C., Theobald, N. and Bester, K. 2007. Emerging Pollutants in the North Sea in Comparison to Lake Ontario, Canada, Data. Environ. Toxicol. Chem., 26: 1081 - 1089.
3. Benotti, M.J., Trenholm, R.A., Vanderford, B.J., Holady, J.C., Stanford, B.D. and Snyder, S.A. 2009. Pharmaceutical Substances and Endocrine Disrupting Compounds in U.S. Drinking Water. Environ. Sci. Technol., 43: 597 - 603.
4. Bialk-Bielinska, A., Stolte, S., Arning, J., Uebers, U., Boschen, A., Stepnowski, P. and Matzke, M. 2011. Ecotoxicity Evaluation of Selected Sulfonamides. Chemosphere, 85: 928 - 933.
5. Buszka, P.M., Yeskis, D.J., Kolpin, D.W., Furlong, E.T., Zaugg, S.D. and Meyer, M.T. 2009. Waste Indicator and Pharmaceutical Compounds in Landfill Leachate Affected Ground Water Near Elkhart, Indiana, 2000-2002. Bull. Environ. Contam. Toxicol., 82: 653 - 659.
6. Carballa, M., Omil, F., Lema, J.M., Llompart, M., Garcia-Jares, C., Rodriguez, L., Gomez, M. and Ternes, T. 2004. Behavior of Pharmaceutical Substances, Cosmetics, and Hormones in a Sewage Treatment Plant. Water Res., 38 (12): 2918 - 2926.
7. Carlsson, C., Johansson, A.-K., Alvan, G., Bergman, K. and Kuhler, T. 2006. Are Pharmaceutical Substances Potent Environmental Pollutants? Part I: Environmental Risk Assessments of Selected Active Pharmaceutical Ingredients. Sci. Total Environ., 364: 67 - 87.
8. Carrara, C., Ptacek, C.J., Robertson, W.D., Blowes, D.W., Moncur, M.C., Sverko, E. and Backus, S. 2008. Fate of Pharmaceutical and Trace Organic Compounds in Three Septic System Plumes, Ontario, Canada. Environ. Sci. Technol., 42: 2805 - 2811.
9. Christensen, A.M., Faaborg-Andersen, S., Ingerslev, F. and Baun, A. 2007. Mixture and Single Substance Toxicity of Selective Serotonin Reuptale Inhibitors Toward Algae and Crustaceans. Environ. Toxicol. Chem., 26: 85 - 91.
10. Cunningham, V.L., Binks, S.P. and Olson, M.J. 2009. Human Health Risk Assessment from the Presence of Human Pharmaceutical Substances in the Aquatic Environment. Regul. Toxicol. Pharm., 53: 39 - 45.
11. De Oliveira, A.J.F. and Pinhata, J.M.W. 2008. Antimicrobial Resistance and Species Composition of Enterococcus spp. Isolated from Waters and Sands of Marine Recreational Beaches in Southeastern Brazil. Water Res., 42: 2242 - 2250.
12. Escher, B.I., Baumgartner, R., Koller, M., Treyer, K., Lienert, J. and McArdell, C.S. 2011. Environmental Toxicology and Risk Assessment of Pharmaceutical Substances from Hospital Wastewater. Water Res., 45: 75 - 92.
13. Farré, M., Ferrer, I., Ginebreda, A., Figueras, M., Olivella, L. Tirapu, L. 2001. Determination of Drugs in Surface Water and Wastewater Samples by Liquid Chromatography-Mass Spectrometry: Methods and Preliminary Results Including Toxicity Studies with Vibrio fischeri. J. Chromatogr. A, 938: 187 - 197.
14. Ferrari, B., Mons, R., Vollat, B., Fraysse, B., Paxeus, N., Giudice, R.L., Pollio, A. and Garric, J. 2004. Environmental Risk Assessment of Six Human Pharmaceuticals: Are the Current Environmental Risk Assessment Procedures Sufficient for the Protection of the Aquatic Environment?. Environ. Toxicol. Chem., 23: 1344 - 1354.
15. Fraysse, B. and Garric, J. 2005. Prediction and Experimental Validation of Acute Toxicity of β-Blockers in Ceriodaphnia Dubia. Environ. Toxicol. Chem., 24: 2470 - 2476.
16. Gabet-Giraud, V., Miege, C., Choubert, J.M., Martin Ruel, S. and Coquery, M. 2010. Occurrence and Removal of Estrogens and Beta Blockers by Various Processes in Wastewater Treatment Plants. Sci. Total Environ., 408: 4257 - 4269.
17. Ginebreda, A., Munoz, I., Lopez de Alda, M., Brix, R., Lopez-Doval, J. and Barcelo, D. 2010. Environmental Risk Assessment of Pharmaceutical Substances in Rivers: Relationships Between Hazard Indexes and Aquatic Macroinvertebrate Diversity Indexes in the Llobregat River (NE Spain). Environ. Int., 36: 153 - 162.
18. Grung, M., E.S. Heimstad, M. Moe, M. Schlabach, A. Svenson, K. Thomas, and A. Woldegiorgis. 2007. "Human and Veterinary Pharmaceutical Substances, Narcotics, And Personal Care Products in the Environment. Current State of Knowledge and Monitoring Requirements." Swedish Environmental Research Institute. Report http://www.klif.no/publikasjoner/2325/ta2325.pdf (http://www.klif.no/publikasjoner/2325/ta2325.pdf)
19. Grung, M., Kallqvist, T., Sakshaug, S., Skurtveit, S. and Thomas, K.V. 2008. Environmental Assessment of Norwegian Priority Pharmaceutical Substances Based on the EMEA Guideline. Ecotoxicol. Environ. Saf., 71: 328 - 340.
20. Helm, P.A., Howell, E.T., Li, H., Metcalfe, T.L., Chomicki, K.M. and Metcalfe, C.D. 2012. Influence of Nearshore Dynamics on the Distribution of Organic Wastewater-Associated Chemicals in Lake Ontario Determined Using Passive Samplers. J. Great Lakes Res., 38: 105 - 115.
21. Hernando, M.D., Mezcua, M., Fernández-Alba, A.R. and Barceló, D. 2006. Environmental Risk Assessment of Pharmaceutical Residues in Wastewater Effluents, Surface Waters and Sediments. Talanta, 69: 334 - 342.
22. Hua, W., Bennett, E.R. and Letcher, R.J. 2006. Ozone Treatment and the Depletion of Detectable Pharmaceuticals and Atrazine Herbicide in Drinking Water Sourced from the Upper Detroit River, Ontario, Canada. Wat. Res., 40: 2259 - 2266.
23. Huerta-Fontela, M., Galceran, M.T. and Ventura, F. 2008. Stimulatory Drugs of Abuse in Surface Waters and Their Removal in a Conventional Drinking Water Treatment Plant. Environ. Sci. Technol., 42: 6809 - 6816.
24. IJC-2009. 2009. Great Lakes Water Quality Agreement Priorities 2007-09 Series. Work Group Report on Great Lakes Chemicals of Emerging Concern, 2009. International Joint Commission (IJC), Special Publication 2009-01, Windsor, Ontario, Canada http://www.ijc.org/en/priorities/2009/reports/2009-chemicals.pdf
25. IJC-2011. 2011a. Chemicals of Emerging Concern. Great Lakes Water Quality Agreement 2009-2011 Priority Cycle Report, IJC(2011) http://meeting.ijc.org/workgroups/cec
26. th. January 2011. Biennial Report on Great Lakes Water Quality January, IJC Canada and the United States http://www.ijc.org/rel/boards/watershed/15biennial_report_web-final.pdf
27. Illinois Environment Protection Agency (EPA). 2008. Report on Pharmaceutical Substances and Personal Care Products in Illinois Drinking Water Bureau of Water, Springfield, IL: Illinois EPA.
28. Jasim, S.Y., Irabelli, A., Yang, P., Ahmed, S. and Schweitzer, L. 2006. Presence of Pharmaceutical Substances and Pesticides in Detroit River Water and the Effect of Ozone on Removal. Ozone: Sci. Eng., 28 (6): 415 - 423.
29. Kim, Y., Choi, K., Jung, J., Park, S., Kim, P.-G. and Park, J. 2007. Aquatic Toxicity of Acetaminophen, Carbamazepine, Cimetidine, Diltiazem and Six Major Sulfonamides, and Their Potential Ecological Risks in Korea. Environ. Int., 33: 370 - 375.
30. Kim, J.-W., Ishibashi, H., Yamauchi, R., Ichikawa, N., Takao, Y., Hirano, M., Koga, M. and Arizono, K. 2009. Acute Toxicity of Pharmaceutical and Personal Care Products on Freshwater Crustacean (Thamnocephalus platyurus) and Fish (Oryzias latipes). J. Toxicol. Sci., 34: 227 - 232.
31. Klecka, G., Persoon, C. and Currie, R. 2010. Chemicals of Emerging Concern in the Great Lakes Basin: An Analysis of Environmental Exposures. Rev. Environ. Contam. Toxicol., 207: 1 - 93.
32. Kleywegt, S., Pileggi, V., Yang, P., Hao, C., Zhao, X., Rocks, C., Thach, S., Cheung, P. and Whitehead, B. 2011. Pharmaceutical Substances, Hormones and Bisphenol A in Untreated Source and Finished Drinking Water in Ontario, Canada - Occurrence and Treatment Efficiency. Sci. Total Environ., 409: 1481 - 1488.
33. Kormos, J.L. 2007. " Occurrence and Seasonal Variability of Selected Pharmaceutical Substances in Southern Ontario Drinking Water Supplies. In MSc. Thesis, Biology, University of Waterloo Waterloo, Ontario, Canada
34. Kummerer, K. and Henninger, A. 2003. Promoting Resistance by the Emission of Antibiotics from Hospitals and Households into Effluent. Clin. Microbiol. Infect., 9: 1203 - 1214.
35. Lavén, M., Alsberg, T., Yu, Y., Adolfsson-Erici, M. and Sun, H. 2009. Serial Mixed-Mode Cation- and Anion-Exchange Solid-Phase Extraction for Separation of Basic, Neutral and Acidic Pharmaceuticals in Wastewater and Analysis by High-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry. J. Chromatogr. A, 1216: 49 - 62.
36. Lee, H.B., Sarafin, K. and Peart, T.E. 2007. Determination of β-Blockers and β2-Agonists in Sewage by Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. A, 1148: 158 - 167.
37. Lee, H.B., Peart, T.E., Svoboda, M.L. and Backus, S. 2009. Occurrence and Fate of Rosuvastatin, Rosuvastatin Lactone, and Atorvastatin in Canadian Sewage and Surface Water Samples. Chemosphere, 77: 1285 - 1291.
38. Li, H., Helm, P.A. and Metcalfe, C.D. 2010. Sampling in the Great Lakes for Pharmaceuticals, Personal Care Products, and Endocrine-Disrupting Substances Using Passive Polar Organic Chemical Integrative Sampler. Environ. Toxicol. Chem., 29: 751 - 762.
39. Metcalfe, C.D., Metcalfe, R.L., Kiparissis, Y., Koenig, B.G., Khan, C., Hughes, R.J., Croley, T.R., March, R.E. and Potter, T. 2001. Estrogenic Potency of Chemicals Detected in Sewage Treatment Plant Effluents as Determined by in vivo Assays with Japanese Medaka (Oryzias Latipes). Environ. Toxicol. Chem., 20: 297 - 308.
40. Metcalfe, C.D., Chu, S., Judt, C., Li, H., Oakes, K.D., Servos, M.R. and Andrews, D.M. 2010. Antidepressants and Their Metabolites in Municipal Wastewater, and Downstream Exposure in an Urban Watershed. Environ. Toxicol. Chem., 29: 79 - 89.
41. Milwaukee Water Works Water Quality Section. 2008. Tests of Lake Michigan water source of Milwaukee Drinking Water, 2008 Annual Water Quality Report. http://city.milwaukee.gov/ImageLibrary/Groups/WaterWorks/files/2010LakeMichiganSourceWaterTes.pdf
42. Nakada, N., Shinohara, H., Murata, A., Kiri, K., Managaki, S., Sato, N. and Takada, H. 2007. Removal of Selected Pharmaceuticals and Personal Care Products (PPCPs) and Endocrine-Disrupting Chemicals (EDCs) during Sand Filtration and Ozonation at a Municipal Sewage Treatment Plant. Water Res., 41 (19): 4373 - 4382.
43. Oulton, R.L., Kohn, T. and Cwiertny, D.M. 2010. Pharmaceuticals and Personal Care Products in Effluent Matrices: A Survey of Transformation and Removal During Wastewater Treatment and Implications for Wastewater Management. J. Environ. Monitor., 12: 1956 - 1978.
44. Park, S. and Choi, K. 2008. Hazard Assessment of Commonly Used Agricultural Antibiotics on Aquatic Ecosystems. Ecotoxicology, 17: 526 - 538.
45. Press-Kristensen, K., Ledin, A., Schmidt, J.E. and Henze, M. 2007. Identifying Model Pollutants to Investigate Biodegradation of Hazardous XOCs in WWTPs. Sci. Total Environ., 373: 122 - 130.
46. Quinn, B., Gagne, F. and Blaise, C. 2008. An Investigation into the Acute and Chronic Toxicity of Eleven Pharmaceutical Substances (and Their Solvents) Found in Wastewater Effluent on the Cnidarian, Hydra Attenuate. Sci. Total Environ., 389: 306 - 314.
47. Rahman, M.F., Yanful, E.K., Jasim, S.Y., Bragg, L.M., Servos, M.R., Ndiongue, S. and Borikar, D. 2010. Advanced Oxidation Treatment of Drinking Water: Part 1. Occurrence and Removal of Pharmaceutical Substances and Endocrine Disrupting Compounds from Lake Huron Water. Ozone: Sci. Eng., 32: 217 - 229.
48. Radjenović, J., Petrović, M., Ventura, F. and Barceló, D. 2008. Rejection of Pharmaceuticals in Nanofiltration and Reverse Osmosis Membrane Drinking Water Treatment. Wat. Res., 42: 3601 - 3610.
49. Schwab, B.W., Hayes, E.P., Fiori, J.M., Mastrocco, F.J., Roden, N.M., Cragin, D., Meyerhoff, R., 'Aco, V.J. D and Anderson, P.D. 2005. Human Pharmaceutical Substances in US Surface Water: A Human Health Risk Assessment. Regul. Toxicol. Pharmacol., 42: 296 - 312.
50. Scheurer, M., Ramil, M., Metcalfe, C.D., Groh, S. and Ternes, T.A. 2010. The Challenge of Analyzing Beta-Blocker Drugs in Sludge and Wastewater. Anal. Bioanal. Chem., 396: 845 - 856.
51. Spongberg, A.L. and Witter, J.D. 2008. Pharmaceutical Compounds in the Wastewater Process Stream in Northwest Ontario. Sci. Total Environ., 397: 148 - 157.
52. Styrishave, B., Halling-Sorensen, B. and Ingerslev, F. 2011. Environmental Risk Assessment of Three Selective Serotonin Reuptake Inhibitors in the Aquatic Environment. A Case Study Including a Cocktail Scenario. Environ. Toxicol. Chem., 30: 254 - 261.
53. Sui, Q., Huang, J., Deng, S., Yu, G. and Fan, Q. 2010. Occurrence and Removal of Pharmaceuticals, Caffeine and DEET in Wastewater Treatment Plants of Beijing, China. Wat. Res., 44: 417 - 426.
54. Tabe, S., Jamal, T., Seth, R., Yue, C., Yang, P., Zhao, X. and Schweitzer, L. 2009. PPCPs and EDCs-Occurrence in the Detroit River and Their Removal by Ozonation. Final Report. Denver, CO: Water Research Foundation
55. Valcarcel, Y., Alonso, G., Rodriguez-Gil, J.L., Gil, A. and Catala, M. 2011. Detection of Pharmaceutically Active Compounds in the Rivers and Tap Water of the Madrid Region (Spain) and Potential Ecotoxicological Risk. Chemosphere, 84: 1336 - 1348.
56. Waiser, M.J., Humphries, D., Tumber, V. and Holm, J. 2011. Effluent-Dominated Streams. Part 2: Presence and Possible Effects of Pharmaceutical Substances and Personal Care Products in Wascana Creek, Saskatchewan, Canada. Environ. Toxicol. Chem., 30: 508 - 519.
57. Watkinson, A.J., Murby, E.J. and Costanzo, S.D. 2007. Removal of Antibiotics in Conventional and Advanced Wastewater Treatment: Implications for Environmental Discharge and Wastewater Recycling.". Wat. Res., 41: 4164 - 4176.
58. Watkinson, A.J., Murby, E.J., Kolpin, D.W. and Costanzo, S.D. 2009. The Occurrence of Antibiotics in an Urban Watershed: From Wastewater to Drinking Water. Sci. Total Environ., 407: 2711 - 2723.
59. Westerhoff, P., Yoon, Y., Snyder, S. and Wert, E. 2005. Fate of Endocrine-Disruptor, Pharmaceutical Substances, and Personal Care Product Chemicals During Simulated Drinking Water Treatment Processes. Environ. Sci. Technol., 39: 6649 - 6663.
60. Wu, C., Spongberg, A.L. and Witter, J.D. 2008. Use of Solid Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Various Pharmaceutical Substances in Surface Water. Int. J. Environ. Anal. Chem., 88: 1033 - 1048.
61. Wu, C., Witter, J.D., Spongberg, A.L. and Czajkowski, K.P. 2009. Occurrence of Selected Pharmaceutical Substances in an Agricultural Landscape, Western Lake Erie Basin. Water Res., 43: 3407 - 341.